{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-026534","form_type":"8-K","ticker":"STSS","cik":"0001737995","company_name":"Sharps Technology Inc.","filed_at":"2026-06-01T12:15:14+00:00","discovered_at":"2026-06-01T12:20:00.233530+00:00","generated_at":"2026-06-01T12:20:43.730314+00:00","sec_items":["5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Sharps Technology rebrands as SkyAI, pivots to AI finance platform for Global South","bullets":["Company changed name to SkyAI, Inc.; new tickers SKYA (common) and SKYAW (warrants) effective May 28, 2026.","Opened Hong Kong operational headquarters for licensing and talent; building agentic finance platform on Solana blockchain.","Targets Global South (~85% of world population); stablecoin adoption >500M users; on-chain value grew 69% YoY in Asia-Pacific.","Platform combines AI and stablecoin rails to offer U.S. dollar-denominated savings, financial education, and data insights.","CIO Alice Zhang (former Jambo co-founder) leads development; company calls it a high-conviction opportunity."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026534","json":"https://secwatch.observer/filing/0001493152-26-026534.json","markdown":"https://secwatch.observer/filing/0001493152-26-026534.md","text":"https://secwatch.observer/filing/0001493152-26-026534.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737995/000149315226026534/0001493152-26-026534-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737995/000149315226026534/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T12:20:43.730314+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001193125-26-251399","ticker":"IDYA","company_name":"IDEAYA Biosciences, Inc.","filed_at":"2026-06-01T20:05:32+00:00","headline":"IDEAYA's darovasertib combo meets primary endpoint in Phase 2/3 OptimUM-02 trial for metastatic uveal melanoma","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251399","json":"https://secwatch.observer/filing/0001193125-26-251399.json","markdown":"https://secwatch.observer/filing/0001193125-26-251399.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676725/000119312526251399/0001193125-26-251399-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676725/000119312526251399/d138848d8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-251394","ticker":"FULC","company_name":"Fulcrum Therapeutics, Inc.","filed_at":"2026-06-01T20:05:16+00:00","headline":"Fulcrum Therapeutics discontinues pociredir program in SCD; initiates strategic review","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-251394","json":"https://secwatch.observer/filing/0001193125-26-251394.json","markdown":"https://secwatch.observer/filing/0001193125-26-251394.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526251394/0001193125-26-251394-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1680581/000119312526251394/fulc-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001628280-26-039297","ticker":"GPRO","company_name":"GoPro, Inc.","filed_at":"2026-06-01T13:12:22+00:00","headline":"GoPro refiles financials with going-concern warning; potential defaults on debt","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-039297","json":"https://secwatch.observer/filing/0001628280-26-039297.json","markdown":"https://secwatch.observer/filing/0001628280-26-039297.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1500435/000162828026039297/0001628280-26-039297-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1500435/000162828026039297/gpro-20260601.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-063161","ticker":"OPTU","company_name":"Optimum Communications, Inc.","filed_at":"2026-06-01T12:16:33+00:00","headline":"Optimum raises $500M via preferred units, starts $300M tender at $2.50 to shield assets from CSC debt","event_type":"other_material","sec_items":["1.01","3.02","7.01","8.01","9.01"],"materiality_score":0.9,"calibrated_materiality_score":0.9,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-063161","json":"https://secwatch.observer/filing/0001213900-26-063161.json","markdown":"https://secwatch.observer/filing/0001213900-26-063161.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1702780/000121390026063161/0001213900-26-063161-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1702780/000121390026063161/ea0292871-8k_optimum.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-068595","ticker":"ZSPC","company_name":"zSpace, Inc.","filed_at":"2026-06-01T12:00:56+00:00","headline":"zSpace restructures $12M debt via equity conversion; creates Series P-2 preferred","event_type":"other_material","sec_items":["1.01","1.02","2.03","3.02","5.03","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068595","json":"https://secwatch.observer/filing/0001104659-26-068595.json","markdown":"https://secwatch.observer/filing/0001104659-26-068595.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1637147/000110465926068595/0001104659-26-068595-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1637147/000110465926068595/tm2616116d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-249725","ticker":"EIKN","company_name":"Eikon Therapeutics, Inc.","filed_at":"2026-06-01T11:30:25+00:00","headline":"Eikon reports 63.1% ORR in Phase 2 NSCLC trial of EIK1001; PARP1 inhibitor EIK1003 shows 24.5% ORR with paclitaxel","event_type":"other_material","sec_items":["7.01","8.01","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-249725","json":"https://secwatch.observer/filing/0001193125-26-249725.json","markdown":"https://secwatch.observer/filing/0001193125-26-249725.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526249725/0001193125-26-249725-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1861123/000119312526249725/eikn-20260530.htm"},"side_by_side_evidence":null},{"accession":"0001599298-26-000043","ticker":"SMMT","company_name":"Summit Therapeutics Inc.","filed_at":"2026-06-01T10:57:20+00:00","headline":"Ivonescimab: 70.8% ORR in mCRC Phase II; HARMONi-6 OS HR 0.66 vs tislelizumab","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001599298-26-000043","json":"https://secwatch.observer/filing/0001599298-26-000043.json","markdown":"https://secwatch.observer/filing/0001599298-26-000043.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1599298/000159929826000043/0001599298-26-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1599298/000159929826000043/smmt-20260530.htm"},"side_by_side_evidence":null},{"accession":"0001829126-26-005831","ticker":"FXAC","company_name":"FortuneX Acquisition Corp","filed_at":"2026-05-29T21:32:49+00:00","headline":"FortuneX Acquisition closes IPO of 8.625M units at $10/unit, raising $86.25M gross","event_type":"other_material","sec_items":["1.01","3.02","5.02","5.03","9.01"],"materiality_score":0.8,"calibrated_materiality_score":0.8,"match_reasons":["same SEC item: 5.03, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001829126-26-005831","json":"https://secwatch.observer/filing/0001829126-26-005831.json","markdown":"https://secwatch.observer/filing/0001829126-26-005831.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/0001829126-26-005831-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2121703/000182912626005831/fortunexacq_8k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}